AkditalCAS:AKT -0.34%83 Buyback Yield % is -0.01 as of Jul. 11, 2026. GuruFocus rates CAS:AKT with a GF Score™ of 83/100 and a GF Value™ of MAD2,133.55 (Possible Value Trap). The stock has 5 warning signs investors should review. Among 276 Healthcare Providers & Services companies, Akdital ranks better than 53.62% on this metric.
Buyback yield is the net repurchase of shares outstanding over the market capital of the company. It is a measure of shareholder return.
The historical data trend for Akdital's Buyback Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
CAS:AKT vs HCA, THC, DVA: Buyback Yield % Comparison
For the Medical Care Facilities subindustry, Akdital's Buyback Yield %, along with its competitors' market caps and Buyback Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Akdital Buyback Yield % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Akdital's Buyback Yield % distribution charts can be found below:
* The bar in red indicates where Akdital's Buyback Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Akdital (CAS:AKT) has a Buyback Yield % of -0.01 as of Jul. 11, 2026. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Akdital and its competitors. According to the industry distribution chart, Akdital ranks #128 out of 276 companies in the Healthcare Providers & Services industry, placing it in the top 46.4%.
Is Akdital's Buyback Yield % too high?
Akdital's current Buyback Yield % is -0.01. Based on the distribution chart, Akdital ranks #128 out of 276 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Akdital has a GF Score™ of 83/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Akdital's Buyback Yield % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Akdital ranks #128 out of 276 companies for Buyback Yield %. This puts Akdital in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Buyback Yield % for a Healthcare Providers & Services company?
A good Buyback Yield % depends on the Healthcare Providers & Services industry context. However, Buyback Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Buyback Yield % mean?
A high Buyback Yield % can signal that a stock is expensive relative to its fundamentals. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Akdital and its competitors. Akdital's current Buyback Yield % is -0.01. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Akdital stock overvalued right now?
Based on GuruFocus' analysis, Akdital (CAS:AKT) is currently considered Possible Value Trap. The stock's GF Value™ is MAD2,133.55, compared to a current price of MAD1,164.00 — trading 45.4% below its estimated fair value. The current Buyback Yield % is -0.01. Akdital's overall GF Score™ is 83/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Buyback Yield % calculated?
Buyback Yield % is calculated from a company's financial statements. For Akdital (CAS:AKT), the current Buyback Yield % is -0.01 as of Jul. 11, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Akdital (CAS:AKT) Overvalued in 2026?
Based on GuruFocus' analysis, Akdital stock appears to be undervalued.
The current stock price of MAD1,164.00 is trading 45.4% below its estimated GF Value™ of MAD2,133.55.
GuruFocus considers Akdital to be Possible Value Trap.
Key valuation signals for CAS:AKT:
Buyback Yield %: -0.01
GF Value™: MAD2,133.55 vs. price of MAD1,164.00 (45.4% below fair value)
No single metric tells the full story. See the CAS:AKT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Akdital operates private healthcare clinics. The company offers healthcare services such as cardiac surgery, oncology, radiotherapy, intensive care, and neonatal care, providing patients with comprehensive care according to international standards.
83GF Score
Get the complete analysis for CAS:AKT
Buyback Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CAS:AKT has been successfully added to your 
